Cite
HARVARD Citation
Atreya, R. et al. (2018). Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis. Digestive and liver disease. 50 (10), pp. 1019-1029. [Online].